Novartis Attributes OTC Sales Growth To Expanding Geographic Reach
This article was originally published in The Tan Sheet
Executive Summary
Growing OTC product sales driven by "ongoing geographic expansion" contributed to a 14 percent increase in Novartis' fiscal 2008 first-quarter consumer health sales, according to the firm
You may also be interested in...
Russia’s Emerging OTC Market Holds Problems As Well As Promise
Russia's rapidly growing over-the-counter market offers pharmaceutical companies a chance to expand their business, but its complex regulations and lengthy registration timelines may hinder entry
Pre-emption Among Legal Hurdles For Triaminic Proposed Class Action
A proposed class action alleging Novartis marketed pediatric cough/cold products that were ineffective and unsafe likely faces an uphill battle, according to industry attorneys including former FDA Chief Counsel Peter Barton Hutt
Infant Cold Products Pulled; Waxman Looks For More OTC Risks
Manufacturers of OTC cough/cold medicines for children under 2 years old are voluntarily withdrawing the products from the market due to potential misuse, not from product safety concerns, the Consumer Healthcare Products Association said Oct. 11